Session Information

  • WCLC 2022

    2022 World Conference on Lung Cancer

    Conference Program for 2022 the World Conference on Lung Cancer

    Presentation Date(s):  
    • August 6 - 9, 2022
    • Total Presentations: 2137

    All times listed are in Vienna, Austria Time, CEST (UTC+2:00)

    PL - Plenary
    IBS - Interactive Breakfast Session (in-person attendees only)
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    P - Posters
    EP - ePosters
    WS - Workshops
    LA – Lectureship Awards
    IS - Industry Symposium

Filter Results:

Show Only CME Accredited Sessions

  • +

    IS14 - Industry Symposium Sponsored by RMEI, Supported by Regeneron and Sanofi: Harnessing the Full Potential of Immunotherapy in Frontline Treatment of Locally Advanced or Metastatic NSCLC

    • 18:00 - 19:00
    • 8/07/2022
    • Location: Hall C7
    • Not for CME Credit
    • Type: Industry Symposium
    • Track:
    • +

      IS14.02 - Use of Biomarker Testing in Advanced NSCLC

      18:05 - 18:20  |  Presenter: Aleks Ryska

      • Abstract

      Loading...

  • +

    MA12 - Pathology: Tumour Diagnostics

    • 10:45 - 11:45
    • 8/09/2022
    • Location: Hall C7
    • Not for CME Credit
    • Type: Mini Oral
    • Track: Pathology
    • +

      Session Moderator

      11:37 - 11:45  |  Presenter: Aleks Ryska

      • Abstract

      Loading...

    • +

      Session Moderator

      11:37 - 11:45  |  Presenter: Deepali Jain

      • Abstract

      Loading...

    • +

      MA12.01 - Session Introduction

      10:45 - 10:46  |  Presenter: Aleks Ryska

      • Abstract

      Loading...

    • +

      MA12.02 - Session Introduction

      10:46 - 10:47  |  Presenter: Deepali Jain

      • Abstract

      Loading...

    • +

      MA12.03 - Mechanims of Immune Evasion in Patients With KRAS-Mutant Lung Adenocarcinoma: A Role of MAPK Pathway Activation

      10:47 - 10:52  |  Presenter: Dwayne Deshon Naves

      • Abstract

      Loading...

    • +

      MA12.04 - SAKK 16/14: CD8 T Cell Positioning Correlates with Survivalin Stage IIIA(N2) NSCLC After Neoadjuvant Immunotherapy

      10:52 - 10:57  |  Presenter: Sacha I Rothschild

      • Abstract

      Loading...

    • +

      MA12.05 - Economic Impact of Delaying Care With Single-Gene Testing Versus Next-Generation Sequencing in Non-small Cell Lung Cancer

      10:57 - 11:02  |  Presenter: Brandon Sheffield

      • Abstract

      Loading...

    • +

      MA12.06 - Discussant

      11:02 - 11:12  |  Presenter: Ming-Sound Tsao

      • Abstract

      Loading...

    • +

      MA12.07 - Defining Morphologic Features of Invasion in Pulmonarynon-Mucinousadenocarcinoma With Lepidic Growth

      11:12 - 11:17  |  Presenter: Erik Thunnissen

      • Abstract

      Loading...

    • +

      MA12.08 - Pagetoid Growth of Squamous Cell Carcinoma with a Subsolid Component

      11:17 - 11:22  |  Presenter: Federica Filipello

      • Abstract

      Loading...

    • +

      MA12.09 - Frequency and Detectability of Uncommon EGFR Mutations in NSCLC

      11:22 - 11:27  |  Presenter: Hazel M O'Sullivan

      • Abstract

      Loading...

    • +

      MA12.10 - Discussant

      11:27 - 11:37  |  Presenter: Mari Mino-Kenudson

      • Abstract

      Loading...

    • +

      MA12.11 - Live Q&A

      11:37 - 11:45

      • Abstract

      Loading...